SCHEDULE: Alvotech Lock-Up and Loan Agreements Filed

Alvotech's major shareholder, Celtic Lux Holdings S.a r.l., has entered into a lock-up agreement and secured a $40 million loan facility, impacting share trading and company financing.

Summary

• Celtic Lux Holdings S.a r.l. (Celtic Lux), a significant shareholder in Alvotech, has entered into a lock-up agreement dated June 10, 2026, restricting the sale of its ordinary shares for a period of 90 days following the date of Alvotech's prospectus supplement.
• Celtic Lux also secured a $40 million senior secured term loan facility on June 26, 2026, with proceeds intended for its investment in Alvotech.
• The loan facility is secured by a pledge of Celtic Lux's Alvotech shares and has a maturity of 12 months from the first utilization.
• The filing also details the purpose of the loan, which is to fund Celtic Lux's PIPE Investment of $38 million for 10,133,333 Alvotech ordinary shares at $3.75 per share.
• Celtic Lux has been granted registration rights for its PIPE investment shares, allowing it to demand registration under the Securities Act.
• The Schedule 13D filing indicates that Celtic Holdings S.C.A. and Celtic Lux Holdings S.a r.l. collectively beneficially own 107,450,988 ordinary shares, representing 27.5% of Alvotech's outstanding shares as of June 18, 2026.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, reflecting standard financial and shareholder agreements that support the company's investment activities and share stability, though the secured loan introduces some risk.

Positives

• Secured $40 million loan facility to support investment in Alvotech.
• Major shareholder (Celtic Lux) committed to a lock-up period, indicating confidence and stability in share trading.
• Registration rights secured for shares purchased in the PIPE investment, allowing for future liquidity.
• Significant ownership stake (27.5%) maintained by Celtic Holdings S.C.A. and Celtic Lux Holdings S.a r.l.

Negatives

• The loan facility is secured by a pledge of Alvotech shares, which could be at risk if the loan terms are not met.
• The loan has a prepayment fee structure, potentially increasing costs if repaid early.
• The company's financial covenant related to Alvotech LTV (Loan-to-Value) must not exceed a certain percentage, with potential for default if breached.

Risks

• Failure to meet loan covenants could lead to the pledged shares being foreclosed upon.
• The lock-up agreement restricts the sale of shares, limiting immediate liquidity for Celtic Lux.
• The effectiveness of the loan and security documents is subject to legal reservations and perfection requirements.
• The company's financial health is tied to the Alvotech LTV ratio, which could be impacted by share price fluctuations.

Future Outlook

The lock-up agreement is in effect for 90 days post-prospectus supplement, impacting potential share sales. The loan facility is secured by Alvotech shares and has a 12-month maturity, with potential implications for the pledged shares based on loan covenants and Alvotech's performance.

Industry Context

StockSavvy.ai notes that this filing details significant financing and shareholder activity for Alvotech, a company in the biopharmaceutical sector. The lock-up agreement and the secured loan facility are common mechanisms used in conjunction with public offerings and private investments to stabilize share prices and provide capital, respectively. The substantial stake held by Celtic Lux indicates a key influential shareholder.

Related Party Transactions

• Celtic Lux Holdings S.a r.l. (a major shareholder) entered into a $40 million loan facility with lenders, secured by Alvotech shares.
• Celtic Lux Holdings S.a r.l. made a $38 million PIPE Investment in Alvotech, a transaction governed by a subscription agreement between the two entities.

Stakeholder Impact

• Shareholders may see increased stability in Alvotech's share price due to the lock-up agreement.
• Lenders to Celtic Lux have security over Alvotech shares, creating a direct financial link.
• The loan facility provides capital for Celtic Lux's investment, potentially supporting Alvotech's strategic initiatives.

Next Steps

• Monitor Alvotech's share price performance and compliance with loan covenants.
• Observe the expiration of the lock-up period and any subsequent share trading activity by Celtic Lux.
• Track the utilization of the loan facility and its impact on Celtic Lux's financial position.

Key Dates

Recommendation

The filing details standard financing and shareholder agreements. While the loan facility provides capital, the pledge of shares introduces risk. The lock-up agreement suggests shareholder confidence but limits immediate liquidity. Without further operational or financial updates from Alvotech itself, a 'hold' recommendation is prudent, pending a clearer view of the company's performance and the impact of these agreements.

Keywords

Alvotech, Celtic Lux Holdings, Lock-Up Agreement, Loan Facility, PIPE Investment, Schedule 13D, Shareholder, Securities Act, Registration Rights, Financing